Serpentis Inquest

From EVE University Wiki
Revision as of 14:24, 21 April 2017 by Djavin novienta (talk | contribs) (Recategorized.)
Jump to: navigation, search

The Serpentis Inquest is a offspring of the Serpentis Corporation that is also a research company, but instead of focusing on neural boosters Inquest is researching black cyber implants and alternative cloning methods.

Attributes

  • Ticker: SPI
  • Headquarters: Serpentis Prime VI - Moon 1 - Serpentis Inquest Biotech Research Center
  • Offices: 1 in 1 systems
  • Shares: 332427989
  • Share price: 81
  • Activity: Biotech
  • Partner: Eifyr and Co.
  • Competitor: Zero-G Research Firm

CEO

Otuwiri Huohalen

Divisions

Administration

  • CFO: Achi Astenaisen

Intelligence

  • Chief Operative: Onlar Skadidsar

Production

  • Production Manager: Engardin Trahad

Personnel

  • Chief of Staff: Ersi Argrik
Retrieved from "https://wiki.eveuniversity.org/index.php?title=Serpentis_Inquest&oldid=120054"